🇺🇸 FDA
Patent

US 11229606

Extended release compositions comprising pyridostigmine

granted A61KA61K31/4425A61K9/0065

Quick answer

US patent 11229606 (Extended release compositions comprising pyridostigmine) held by Amneal Complex Products Research LLC expires Mon Jan 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Amneal Complex Products Research LLC
Grant date
Tue Jan 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/4425, A61K9/0065, A61K9/2846, A61K9/2866